Lactobacillus plantarum CBT LP3 ameliorates colitis via modulating T cells in mice

Da Hye Kim, Soochan Kim, Jae Bum Ahn, Jae Hyeon Kim, Hyun Woo Ma, Dong Hyuk Seo, Xiumei Che, Ki Cheong Park, Jeong Yong Jeon, Sang Yong Kim, Han Cheol Lee, Jae Young Lee, Tae Il Kim, Won Ho Kim, Seung Won Kim, Jae Hee Cheon

Research output: Contribution to journalArticlepeer-review

8 Citations (Scopus)

Abstract

Lactobacillus plantarum has been identified as a probiotic bacterium owing to its role in immune regulation and maintenance of intestinal permeability. Here, we investigated the anti-colitic effects and mechanism of L. plantarum CBT LP3 (LP3). This in vivo study was performed using dextran sodium sulfate (DSS) to induce colitis in mice. Mice were randomly divided into three groups: a control supplied with normal drinking water, a DSS-treated group followed by oral administration of vehicle, and a DSS-treated group gavaged with LP3 daily for 7 days following DSS administration. An analysis of macrophages and T cell subsets harvesting from peritonium cavity cells and splenocytes was performed using a flow cytometric assay. Gene expression and cytokine profiles were measured using quantitative reverse transcriptase polymerase chain reaction. The administration of LP3 significantly attenuated disease activity and histolopathology compared to control. LP3 had anti-inflammatory effects, with increased induction of regulatory T cells and type 2 helper T cells in splenocytes and restoration of goblet cells accompanied by suppression of proinflammatory cytokine expressions. These findings suggest that L. plantarum CBT LP3 can be used as a potent immunomodulator, which has significant implications for IBD treatment.

Original languageEnglish
Article number151391
JournalInternational Journal of Medical Microbiology
Volume310
Issue number2
DOIs
Publication statusPublished - 2020 Feb

Bibliographical note

Funding Information:
This work was supported by a grant from the Ministry of Health & Welfare, Republic of Korea (grant number: HI14C1324), a Mid-career Researcher Program through an NRF grant funded by the Korean government (MSIP) (NRF-2017R1A2B4001848), and Health Fellowship Foundation, as well as Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries (IPET) through Agricultural Microbiome R&D Program, funded by Ministry of Agriculture, Food and Rural Affairs (MAFRA) (918003041SB010).

Funding Information:
This work was supported by a grant from the Ministry of Health & Welfare, Republic of Korea (grant number: HI14C1324 ), a Mid-career Researcher Program through an NRF grant funded by the Korean government ( MSIP ) (NRF- 2017R1A2B4001848 ), and Health Fellowship Foundation, as well as Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries (IPET) through Agricultural Microbiome R&D Program, funded by Ministry of Agriculture, Food and Rural Affairs ( MAFRA ) ( 918003041SB010 ).

Publisher Copyright:
© 2020 The Authors

All Science Journal Classification (ASJC) codes

  • Microbiology
  • Microbiology (medical)
  • Infectious Diseases

Fingerprint

Dive into the research topics of 'Lactobacillus plantarum CBT LP3 ameliorates colitis via modulating T cells in mice'. Together they form a unique fingerprint.

Cite this